Despite significant progress in real-world evidence (RWE), many organizations still struggle to translate their investments into tangible impact with payers and clinicians. While RWE is widely recognized as essential, it is too often treated as a compliance exercise rather than a strategic lever for market access.
Watch our webinar recording to explore why this gap persists and how leading organizations are addressing it. Drawing on insights from a comprehensive Simon-Kucher study across payer, provider, and industry stakeholders, this session highlights how to transform RWE from a “check-the-box” activity into a value-driving capability that strengthens market access across U.S. and global markets.
The session covers:
- Key gaps in integrated evidence generation planning (IEGP) and best practices for developing payer-relevant IEGPs
- Payer and HCP expectations for RWE, and how to equip field teams to deliver clear, compelling, and impactful RWE messages
- Why traditional RWE metrics often fall short and how leading organizations measure RWE value in ways that truly matter
